These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19096862)

  • 1. Rhinitis medicamentosa: what an otolaryngologist needs to know.
    Doshi J
    Eur Arch Otorhinolaryngol; 2009 May; 266(5):623-5. PubMed ID: 19096862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rhinitis medicamentosa in cytological assessment of the nasal mucosa].
    Tarchalska B; Gotlib T; Samoliński B
    Pol Merkur Lekarski; 2005 Sep; 19(111):288-90. PubMed ID: 16358845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhinitis medicamentosa as a cause of increased intraoperative bleeding.
    Robison JG; Pant H; Ferguson BJ
    Laryngoscope; 2010 Oct; 120(10):2106-7. PubMed ID: 20824778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Medically-induced rhinitis].
    Nosulya EV
    Vestn Otorinolaringol; 2017; 82(3):84-90. PubMed ID: 28631690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rhinitis medicamentosa: a nationwide survey of Canadian otolaryngologists.
    Fowler J; Chin CJ; Massoud E
    J Otolaryngol Head Neck Surg; 2019 Dec; 48(1):70. PubMed ID: 31818321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rhinitis medicamentosa: a review of causes and treatment.
    Graf P
    Treat Respir Med; 2005; 4(1):21-9. PubMed ID: 15725047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rhinitis medicamentosa.
    Ramey JT; Bailen E; Lockey RF
    J Investig Allergol Clin Immunol; 2006; 16(3):148-55. PubMed ID: 16784007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical hyaluronic acid in rhinitis medicamentosa: could our perspective be changed?
    Casale M; Vella P; Moffa A; Sabatino L; Rinaldi V; Grimaldi V; Salvinelli F
    J Biol Regul Homeost Agents; 2017 Dec; 31(4 Suppl 2):55-62. PubMed ID: 29202563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ultrastructural changes in human nasal mucosa in rhinitis medicamentosa].
    Knipping S; Holzhausen HJ; Riederer A; Bloching M
    HNO; 2006 Oct; 54(10):742-8. PubMed ID: 16477462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xylitol treats nasal mucosa in rhinitis medicamentosa: an experimental rat model study.
    Cam B; Sari M; Midi A; Gergin O
    Eur Arch Otorhinolaryngol; 2019 Nov; 276(11):3123-3130. PubMed ID: 31468129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term use of oxy- and xylometazoline nasal sprays induces rebound swelling, tolerance, and nasal hyperreactivity.
    Graf P
    Rhinology; 1996 Mar; 34(1):9-13. PubMed ID: 8739860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Research progress on rhinitis medicamentosa].
    Wang YN; Luan ZL; Wang HT
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Nov; 52(11):872-875. PubMed ID: 29141305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rebound congestion and rhinitis medicamentosa: nasal decongestants in clinical practice. Critical review of the literature by a medical panel.
    Mortuaire G; de Gabory L; François M; Massé G; Bloch F; Brion N; Jankowski R; Serrano E
    Eur Ann Otorhinolaryngol Head Neck Dis; 2013 Jun; 130(3):137-44. PubMed ID: 23375990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms and mediators of nasal symptoms in non-allergic rhinitis.
    Salib RJ; Harries PG; Nair SB; Howarth PH
    Clin Exp Allergy; 2008 Mar; 38(3):393-404. PubMed ID: 18201248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The rebound of nasal resistance after decongestant used in nose].
    Shen J; Huang X; Xiang J; Shu H
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1999 Dec; 13(12):560-1. PubMed ID: 12541428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Rhinitis Medicamentosa: A Systematic Review.
    Zucker SM; Barton BM; McCoul ED
    Otolaryngol Head Neck Surg; 2019 Mar; 160(3):429-438. PubMed ID: 30325708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased frequency of rhinitis medicamentosa due to media advertising for nasal topical decongestants.
    Archontaki M; Symvoulakis EK; Hajiioannou JK; Stamou AK; Kastrinakis S; Bizaki AJ; Kyrmizakis DE
    B-ENT; 2009; 5(3):159-62. PubMed ID: 19902852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhinitis medicamentosa: the forgotten factor in nasal obstruction.
    Mabry RL
    South Med J; 1982 Jul; 75(7):817-9. PubMed ID: 6178170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should Excess Topical Decongestant Use Raise a Red Flag? Rhinitis Medicamentosa and Opioid Use Disorder.
    Patel A; Levi JR; Brook CD
    Ann Otol Rhinol Laryngol; 2020 Feb; 129(2):164-169. PubMed ID: 31581795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal changes in rhinitis medicamentosa.
    Lin CY; Cheng PH; Fang SY
    Ann Otol Rhinol Laryngol; 2004 Feb; 113(2):147-51. PubMed ID: 14994772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.